|Day's range||N/A - N/A|
Q2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today announced its collaboration with the University of Texas Medical Branch (UTMB) to develop a novel assay for COVID-19 (SARS-CoV-2) tests, an essential tool for rapid development of a Coronavirus vaccine. Once a viable assay is developed, Q2 Solutions labs will produce it for use in clinical trials to determine the effectiveness of a COVID-19 vaccine.
IQVIA™ (NYSE: IQV), a leader in human data science, today announced the launch of Avacare Clinical Research Network™, a technology-based global site network that opens opportunities for more clinical trials at experienced clinical and research sites. Avacare’s unique analytical tools help sites in Avacare’s network match patients to clinical trials faster and more effectively.
Ari Bousbib has been the CEO of IQVIA Holdings Inc. (NYSE:IQV) since 2016. First, this article will compare CEO...
IQVIA (IQV) delivered earnings and revenue surprises of 1.16% and 1.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
IQVIA Reports Fourth-Quarter and Full-Year 2019 Results; Issues First-Quarter and Full-Year 2020 Guidance
IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQVIA (IQV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IQVIA™ (NYSE: IQV) today announced the launch of the FluSTAR mobile application to help consumers understand and track flu and cold severity this winter. IQVIA’s FluStar app uses near real-time updates complied at www.FluSTAR.com, for current illness information for every ZIP code in the country, accessible from any mobile device.
Solid technological suite, growth opportunities from emerging markets and efforts to boost its presence in real-world business are the major positives for IQVIA Holdings (IQV).